FDA Inspection 1278660 — U of Nebraska Med Ctr

U of Nebraska Med Ctr — FEI 1928186

The FDA completed an inspection of U of Nebraska Med Ctr on August 8, 2025 in Omaha, NE. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 8, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Omaha, NE (United States)

Additional Details

IRB